Goulbourne, C., & Vaux, D. (2010). HIV protease inhibitors inhibit FACE1/ZMPSTE24: A mechanism for acquired lipodystrophy in patients on highly active antiretroviral therapy? Portland Press.
Chicago-čujuhus (17. p.)Goulbourne, C., juo D. Vaux. HIV Protease Inhibitors Inhibit FACE1/ZMPSTE24: A Mechanism for Acquired Lipodystrophy in Patients on Highly Active Antiretroviral Therapy? Portland Press, 2010.
MLA-čujuhus (9. p.)Goulbourne, C., juo D. Vaux. HIV Protease Inhibitors Inhibit FACE1/ZMPSTE24: A Mechanism for Acquired Lipodystrophy in Patients on Highly Active Antiretroviral Therapy? Portland Press, 2010.
Muitte dárkkistit čujuhemiid riektatvuođa, ovdal go geavahat daid iežat deavsttas.